Bli medlem
Bli medlem

Du är här


Weifa ASA : Distribution agreement in Finland for unique pain products

Weifa has signed a 5-year distribution agreement with the Fysioline Group
(Finland). The agreement covers several of Weifa's most recently launched
products within the pain category, and can be extended to include additional
products. Fysioline will sell, market, and distribute the products on an
exclusive basis in the Finnish market under Weifa's brand names. The first
product will be launched towards the end of 2016.

Fysioline is the leading Finnish wellness and fitness company, and is
currently expanding its pharma division. The company has several
market-leading brands within the pain and joint/muscle categories, sold
through Pharmacies.

"We are very happy to have signed our first collaboration agreement for the
Finnish market. This represents an important first step in building a Nordic
platform for our established Weifa brands. The first two products represent a
combined annual peak-sales potential (3-5 years from launch) for Weifa in the
high single-digit million range (NOK). As announced in June 2015, we aim to
expand our business in the Nordic region through different types of
partnerships and acquisitions. In December 2015, we acquired Asan and Sana
with sales in Norway and Sweden, and now we have made our first move into
Finland", says Kathrine Gamborg Andreassen (CEO Weifa).

For further information, please contact:

Kathrine Gamborg Andreassen
+47 95 17 86 80

About Weifa:
Weifa is Norway's leading Consumer health company. Weifa supplies
pharmaceutical products and lifestyle products that address the essential
needs of consumers, customers and professional partners. The Company has a
strong position in Norway and is the market leader in pain relief, with
well-established brands such as Paracet and Ibux, and is also present in
other key areas such as intimate care, dietary supplements and treatment for
colds and respiratory problems. Weifa is listed on the Oslo Stock Exchange
and has its head office in Oslo. In 2015, the Group had a turnover of
approximately NOK 332m (after adjusting for the divestment of the B2B
business). The company currently has approximately 30 employees.

About Fysioline:
The Fysioline Group is the leading provider of fitness and healthcare products
and services in Finland. Its chain of fitness and wellness centers holds a
market leading position within the areas of physiotherapy, rehabilitation and
fitness, and the company is also the dominating supplier of equipment for
these sectors. The Pharma division has developed several market leading
brands within the pain and joint/muscle categories, including the IcePower
product range, which is exported to some 50 countries. Fysioline's range of
Medical Devices and drug products is actively marketed to health-care
professionals and consumers around Finland, and is sold exclusively through
Pharmacies. The Group was founded in 1990, and is privately held. Total Group
revenues amounted to some Euro 40 million in 2015.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Weifa ASA via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.